MRI-guided radiation for locally advanced pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests a way to give radiation therapy for pancreatic cancer using MRI scans to guide the treatment. It aims to make the radiation more precise and possibly more effective, and you will receive chemotherapy first, followed by radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pancreatic cancer that is either not removable by surgery, borderline removable, or you cannot have surgery due to other medical reasons.
- You have not had radiation therapy to the area of the tumor before.
- Your overall health is good enough (performance status above 70) to receive chemotherapy followed by radiation therapy.
- Your blood counts (white blood cells, platelets, hemoglobin) and kidney function (BUN, creatinine) meet the required levels.
- You are able to undergo MRI scans (no metal implants or severe claustrophobia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a precise type of radiation therapy guided by MRI for people with locally advanced pancreatic cancer. It aims to treat the tumor while protecting nearby healthy tissue, potentially improving outcomes after chemotherapy.
This trial tests a combination of standard chemotherapy, MRI-guided radiation, and surgery for people with locally advanced pancreatic cancer that might be removable. The goal is to see if this approach can make more tumors resectable.
This trial studies whether adding an MRI scan improves the selection of people with pancreatic cancer who may benefit from surgery. It focuses on patients without liver spread and with tumors that are borderline or likely removable.
This trial tests a new treatment that uses tiny alpha radiation sources placed directly into the tumor to destroy cancer cells. It is for people with pancreatic cancer that has not spread but cannot be removed surgically, and who have already tried at least one type of chemotherapy or cannot take more chemo.
This trial tests a new treatment called DaRT, which places tiny radioactive devices directly into your pancreatic tumor. It is for people with locally advanced pancreatic cancer that has not spread, after they have already had standard chemotherapy.
This trial tests whether focused radiation on nerves in the abdomen can reduce pain from advanced pancreatic cancer. If you join, you'll receive this treatment and your pain levels will be monitored.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.